Evidence map›Paper›PMID 38350671›Full record

Trial reportBMJ open diabetes research & care2024

Racial differences in measures of glycemia in the Vitamin D and Type 2 Diabetes (D2d) Study: a secondary analysis of a randomized trial.

Erin S LeBlanc, Anastassios G Pittas, Jason Nelson, Ranee Chatterjee, Neda Rasouli, Mary K Rhee, Richard E Pratley, Cyrus V Desouza, Lisa M Neff, Anne M Peters and 3 more

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMJ open diabetes research & care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 1 country.

Erin S LeBlancKaiser Permanente Center for Health Research, Portland, Oregon, USA Erin.S.LeBlanc@kpchr.org.ORCID 0000-0002-4067-3432
Anastassios G PittasDivision of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, Massachusetts, USA.ORCID 0000-0002-0124-7174
Jason NelsonTufts Medical Center, Boston, Massachusetts, USA.
Ranee ChatterjeeInternal Medicine, Duke University, Durham, North Carolina, USA.
Neda RasouliEndocrinology, Metabolism and Diabetes, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.ORCID 0000-0003-1269-3580
Mary K RheeMedicine/Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, Atlanta, Georgia, USA.
Richard E PratleyTranslational Research Institute, AdventHealth Research Institute, Orlando, Florida, USA.ORCID 0000-0002-2912-1389
Cyrus V DesouzaUniversity of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID 0000-0001-6660-0568
Lisa M NeffNorthwestern Medicine, Chicago, Illinois, USA.
Anne M PetersEndocrinology, USC, Manhattan Beach, California, USA.
Samuel Dagogo-JackDivision of Endocrinology, Diabetes & Metabolism General Clinical Research Center, University of Tennessee Health Science Center, Memphis, Tennessee, USA.ORCID 0000-0001-5318-9677
Daniel S HsiaPennington Biomedical Research Center, Baton Rouge, Louisiana, USA.ORCID 0000-0003-2832-3429
D2d Research Group
Tufts Medical Center · USDuke University · USEmory University · USKaiser Permanente Center for Health Research · USNorthwestern Medicine · USPennington Biomedical Research Center · USTranslational Research Institute for Metabolism and Diabetes · USUniversity of Nebraska Medical Center · USUniversity of Tennessee Health Science Center · USVA Eastern Colorado Health Care System · US

Funding

NIDDK NIH HHS U01 DK098245
6 · The paper itself

Abstract

introductionUnderstanding how race may influence the association between A1c and glycemia can improve diabetes screening. We sought to determine whether, for a given A1c level, glucose levels during an oral glucose tolerance test (OGTT) differed by race. RESEARCH DESIGN AND

methodsFrom data collected at 22 US clinical sites, we conducted a cross-sectional study of concurrently measured A1c and OGTT and observational longitudinal follow-up of the subset with high-risk pre-diabetes. Numerical integration methods were used to calculate area under the glycemic curve (AUC

results1016 black, 2658 white, and 193 Asian persons at risk of diabetes were included in cross-sectional analysis. Of these, 2154 with high-risk pre-diabetes were followed for 2.5 years. For a given A1c level, AUC

conclusionsUse of additional testing beyond A1c to screen for diabetes may better stratify diabetes risk in the diverse US population.

Indexed as

Diabetes Mellitus, Type 2Prediabetic StateBlood GlucoseCross-Sectional StudiesGlycated HemoglobinHumansRace FactorsVitamin DVitaminsWhiteBlood GlucoseGlycated HemoglobinVitamin DVitaminsA1CDiabetes Mellitus, Type 2

Identifiers

PMID38350671
PMCPMC10862329
OpenAlexW4391783149

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.